Carregant...
Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis
Tumour necrosis factor (TNF)-α is a key mediator of inflammation in rheumatoid arthritis, and its discovery led to the development of highly successful anti-TNF therapy. Subsequently, other biologic drugs targeting immune pathways, namely interleukin-6 blockade, B cell depletion, and T cell co-stimu...
Guardat en:
| Publicat a: | J Pers Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6963853/ https://ncbi.nlm.nih.gov/pubmed/31581724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm9040046 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|